Plain-English translation of NCT07787247 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This pilot study is testing whether patients with myasthenia gravis can safely use home monitoring devices—like wearable sensors and telemedicine visits—to track their muscle strength and activity levels. The goal is to catch signs that the condition is worsening before it becomes severe enough to need emergency care or hospitalization.
Myasthenia gravis can worsen suddenly and unpredictably, sometimes requiring urgent treatment or hospital admission. Researchers believe that continuous home monitoring combined with regular virtual check-ins with a doctor could help catch these changes early, giving patients time to adjust their treatment before a crisis occurs.
You likely qualify if…
You likely don't qualify if…
You would use home monitoring devices to track your muscle strength and activity, and participate in regular check-in visits with a doctor using telemedicine (video calls). The study team wants to learn whether this approach reliably detects changes in your condition and whether patients find it practical to use regularly. The study involves about 18 participants total and is based in the DC, Maryland, and Virginia area.
AI-generated summary from trial data · Oct 11, 2026 · Not medical advice
United States
Sponsor
George Washington University
Collaborators
EMD Serono Research & Development Institute, Inc.
Enrollment target
~18 participants
Started
August 2026
Primary completion
October 2028
Age range
18 Years and older
Last updated on clinicaltrials.gov in October 2026.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.